Lucence Diagnostics Lucence Presents New Data on Liquid Biopsy for Late-Stage Cancer Monitoring, Treatment Guidance Premium The firm shared validation data at ASCO on its LiquidHallmark assay to help guide detection and treatment decisions for late-stage cancers. Lucence Launches US Validation Study for Liquid Biopsy in Lung Cancer The study will recruit 200 non-small cell lung cancer patients, comparing results of the company's ctDNA testing to tissue next-generation sequencing. Lucence, Waseda University Partner to Develop Laser-Based Liquid Biopsy Platform The partners believe the platform, which captures high resolution images of CTCs and clusters, has potential applications in early cancer detection and disease monitoring. Lucence Obtains CLIA Certification for Palo Alto Lab The firm will scale US-based testing capacity for its LiquidHallmark liquid biopsy assay, which uses amplicon-based technology to detect cancer-related mutations. Lucence Dx Liquid Biopsy Tech Detects Structural Rearrangements, Breast Cancer Mutations Premium In the near term, the firm will launch a laboratory-developed, late-stage lung cancer assay out of its lab in Palo Alto. Jan 27, 2020 Lucence Dx Targets Late-Stage Lung Cancer Monitoring With 2020 US Entry Premium Nov 19, 2019 Cancer Diagnostics Firm Lucence Raises $20M Nov 7, 2019 Lucence Diagnostics, MEDx Partner on Companion Diagnostic Cancer Tests in China Mar 12, 2019 Lucence Dx, Stanford University Applying AI to Liver Cancer Diagnosis, Treatment Nov 26, 2018 Lucence Dx Inks India Distribution Deal for Liquid Biopsy Test Oct 26, 2018 New Products Posted to GenomeWeb: MGI, Lucence Diagnostics, SeraCare, More Sep 18, 2018 Lucence Diagnostics Names Myanmar Distribution Partner for Cancer Dx Tests Aug 13, 2018 Lucence Dx Signs Philippine Distribution Deal for Cancer Tests Breaking News Saga Diagnostics, University College London Cancer Institute Widen Cancer Collaboration New ALS Risk Gene Suggests Role for Apoptosis Weill Cornell Medicine Launches $1.5B Program to Advance Medical Research Danaher to Acquire Aldevron for $9.6B OncoDNA, Institut Jules Bordet Partner on Central Nervous System Metastasis Study Sequencing Study Uncovers MERS-Related Coronavirus in Swiss Bats The Scan Not as High as Hoped The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19. Finding Freshwater DNA A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports. Rise in Payments Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws. Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.